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Abstract The National Cancer Institute (NCI) career devel-
opment (K) awards program supports investigators to de-
velop their cancer research programs and achieve
independence. The NCI Center for Cancer Training con-
ducted a K program evaluation by analyzing outcomes of
awardees and individuals who applied to the program but
were not funded. The evaluation covered seven NCI mech-
anisms (K01, K07, K08, K11, K22, K23, and K25) between
1980 and 2008. Descriptive statistics and regression model-
ing were performed on the full cohort (n=2,893 individuals,
4,081 K applications) and a comparison cohort described
herein. K awardees proportionately received more subse-
quent NIH grants and authored more publications, and time
to first R01 grant was unaffected. Of those not pursuing
research, K awardees were more likely to participate in
activities signaling continued scientific engagement. The
NCI K program had a positive impact, not only on partic-
ipants’ biomedical research careers but also on achieving
outcomes significant to the scientific enterprise.
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Introduction
The National Cancer Institute (NCI) is committed to sup-
porting the career development of cancer researchers and
physician scientists by offering multiple training and career
development programs for graduate students through more
experienced investigators. Some grant mechanisms are
intended to facilitate the transition from mentored scientist
to independent investigator or provide protected time for
newly independent investigators to develop their research
programs, while other grants go directly to research institu-
tions to educate and train predoctoral students and postdoc-
toral or clinical fellows. The spectrum of research career
development opportunities NCI supports reaches scientists,
clinicians, and other health professionals conducting basic,
translational, and clinical cancer research.
The NCI career development (K) awards program has a
longstanding history and has evolved over time to address the
changing cancer research workforce needs. NCI K mecha-
nisms have been consolidated or created to target specific
scientific disciplines, career paths, or populations shown to
be underrepresented in biomedical research. Currently, the
NCI Center for Cancer Training (CCT) supports ten K grant
mechanisms that vary in discipline, program focus, and appli-
cant eligibility. In fiscal year 2011, the CCT supported 365 K
awards at an approximate cost of $65 million.1
Despite its rich history, mixed perceptions exist in the
research community regarding the value of the K program
experience. These concerns seem to focus predominantly on
the K mechanisms that provide early career scientists and
clinicians 3 to 5 years of support, with the overarching goal
1 This is the number of awards and cost from the NIH Information for
Management, Planning, Analysis, and Coordination database (IMPAC
II). These numbers include mechanisms not analyzed in this report
(K05, K24, K99, K12). Total FY 2011 funding for CCT K mechanisms
included in this report was $37.8 million for 258 awards.
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of further developing their cancer research careers or facilitat-
ing their transition to independence. The research career suc-
cesses of K awardees have been questioned, and there is an
undocumented perception that participation in these K pro-
grams delays an individual’s progression to receipt of their
first R01, the NIH gold standard for research independence. In
contrast, unpublished informal analyses and assessments have
demonstrated success of the NCI K program, but no system-
atic, comprehensive evaluation of the program had been con-
ducted thus far. Based on findings from a feasibility study, we
performed an outcome evaluation of the NCI K awards pro-
gram to define the population of individuals who applied for
NCI K awards, to investigate the reality of the above percep-
tions, and to quantitatively determine the impact receipt of a K
award had on pursuit of a biomedical research career and on
contributions to the scientific enterprise. The evaluation ex-
amined five individual K award mechanisms currently offered
by the NCI CCT (K07, K08, K22, K23, and K25) and two K
mechanisms previously phased out by NCI CCT (K01 and
K11).2 Mechanisms not included were mentoring awards for
more senior investigators (K05, K24), a newly established
transition mechanism (K99/R00), and those grants adminis-
tered by NCI’s Center to Reduce Cancer Health Disparities (a
subset of K01, K08, K22, and K23 awards).3 Descriptions of
the K mechanisms can be found in Online Resource 1.
Evaluation highlights are presented in this report, but a de-





The NIH Information for Management, Planning, Analysis,
and Coordination (IMPAC II) database was the primary
source through which information about NCI K applicants
was obtained, including basic demographic information and
data regarding prior and subsequent NIH grant applications.
The Association of American Medical Colleges Faculty
Roster and the National Science Foundation’s Doctorate
Records File were used to supplement demographic informa-
tion from IMPAC II and to provide additional fields to aug-
ment these analyses. The International Cancer Research
Partnership (ICRP) database was used to identify subsequent
awards from non-NIH sources, including the Department of
Defense Congressionally Directed Medical Research
Program, American Cancer Society, Prostate Cancer
Foundation, Susan G. Komen for the Cure, California Breast
Cancer Research Program, and the Canadian Institutes of
Health Research. The Thomson Reuters ScienceWire® grant
catalog was used to match NCI K applicant names to grants
sponsored by the U.S. Department of Energy (DoE) and
National Science Foundation (NSF). Subsequent publications
were collected from the National Library of Medicine’s
MEDLINE. The ClinicalTrials.gov database was used to
match K applicant names to those of key personnel. IMPAC
II and data obtained from the Federal Interagency Databases
Online (FIDO.gov) database were used to collect information
about participation in NIH advisory groups and other Federal
advisory committees. The HealthLink/Lodestone database
was used to identify K applicants registered as clinical practi-
tioners, while the NIH Employee Directory (NED) was used
to identify NIH staff. K applicant membership in selected
professional societies, the American Association for Cancer
Research (AACR), the American Society of Clinical
Oncology (ASCO), and the Federation of American
Societies for Experimental Biology (FASEB), was determined
through name matches to society member databases. The as-
of dates for data sources are noted in Online Resource 2.
Comparison Cohort Derivation
The comparison cohort was constructed using regression-
discontinuity design based on K application priority score,4
an NIH-wide measure of application quality. The compari-
son cohort had equal distribution of K awardees (n=293)
and non-awardees (n=293) whose priority scores clustered
around the funding cutoff, the point at which applicants had
comparable chances of their K applications being funded.
The comparison cohort excluded applicants with maximal
chances of funding and those who were least likely to
receive funding. Such a design permits approximation of
relatively unbiased estimates of program effects [1].
Outcome Analyses
For all individuals in the study, outcomes were measured
starting with the fiscal year following the first NCI K award
(for those with awards) or the last unsuccessful NCI K
2 The full evaluation (http://cancer.gov/researchandfunding/
cancertraining/KAward-Evaluation-Report) examines two additional
NCI K mechanisms, the K04 and K12, which were excluded from this
report. Initial analysis of the demographic and outcome data of the K04
cohort indicated that they were further in their careers than applicants
to the other mechanisms being evaluated. The K12 is an institutional
award for clinical scholars, which presented unique challenges for
demographic and outcome data collection, further detailed in the full
evaluation.
3 The evaluation focused on K mechanisms intended to facilitate the
progression of early career scientists and clinicians into independent
research careers. Mechanisms with a focus outside of this objective or
with too few years of data to collect outcomes were excluded.
4 Each peer-reviewed application is evaluated for merit and assigned a
priority score that reflects consideration of all review criteria.
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application (for non-awardees). Prior grant support was
measured up to the fiscal year preceding the first award or
last unsuccessful application.
For individuals who received a subsequent R01 award as of
FY 2011, the time to R01 value is the numerical difference
between the fiscal year of that first R01 award and the fiscal
year after their first NCI K award or their last unsuccessful NCI
K application. According to this rule, individuals who received
an R01 in the fiscal year immediately following their K award,
or last application, would have a time to R01 value of zero.
To measure publication productivity for each individual,
the number of publications in each fiscal year after their first
NCI K award or last unsuccessful NCI K application was
recorded. Several independent but overlapping matching rules
were used to identify MEDLINE publication records in which
a study applicant appeared as an author. To be considered for
matching, the publication date had to be at least 1 year after the
application date of the last K application for that applicant.
The upper bound for the publication date was April 1, 2011.
These rules are presented in more detail in Online Resource 3.
The matching process was conservative, favoring precision
over recall. This approach results in high confidence in the
papers assigned to individuals, but means that some publica-
tions for individuals are missed.
Data from other non-IMPAC II data sources used a baseline
name match, with corrections applied as necessary based on
quality checks of the matching results. The baseline rule re-
quired an exact first and last name match, and if a middle name
was present in both IMPAC II and the other data source, the first
characters in each string had to match. Common names were
determined by a weighted average of the first and last name
frequencies as measured in IMPAC II, with a threshold deter-
mined by examining a sample of names. All data containing
personally identifiable information were handled and main-
tained in conformancewith the PrivacyAct and applicable legal,
regulatory, and NIH policy requirements regarding privacy.
Statistical Analyses
Unless otherwise noted, Fisher’s exact two-tailed tests were
performed for statistical analyses, using p values <0.05 as
the threshold for significance. All tests were conducted




The conceptual framework, or logic model, for the evaluation is
presented in Fig. 1. Applicant demographics and characteristics
of the K program were analyzed, as well as characteristics of
the applicant institutions to provide context. Outcome data in
three main areas were collected including subsequent research
funding and time to first R01 grant, publication activity, and
career appointments or involvement in the biomedical research
enterprise. Program impact was assessed with regression mod-
eling on a subset of awardees and applicants, exploring a
variety of indicators.
Demographic and career outcome data were collected on
K awardees and K applicants who applied to the program
but were not funded (non-awardees), spanning seven NCI K
mechanisms offered between 1980 and 2008. Table 1 out-
lines the evaluation cohort5 and provides a summary of
application and award volume, numbers of unique appli-
cants and awardees, and percent awarded. Across the seven
NCI K mechanisms, there were a total of 4,081 applications,
of which 1,224 were awarded since 19806 for a funding
award rate of 30 %. The overall success rate for new NCI
research project grants in fiscal years 2002–2011 ranged
from 12.6 to 28.4 % in comparison [2], with the average
being 20.7 %. When examining unique applicants, 1,206
individuals received K awards out of 2,983 applicants, with
an applicant funding rate over 41 %.
We analyzed qualifying degree type, field of study or
medical specialty, race and ethnicity, prior NIH grant support,
and institutional characteristics of K awardees and non-
awardees. The majority of applicants to mechanisms focused
primarily on the non-clinical sciences (e.g., K01, K07, and
K25) held PhDs, while those with a more clinical focus (e.g.,
K08, K11, K23) included a larger proportion of applicants
with MDs. Individuals with MD/PhDs were predominantly in
the K08 and K22 mechanisms. When comparing awardees
and non-awardees, no significant differences were found
based on degree type. Across mechanisms, degree field of
study and clinical specialty of the applicants matched program
focus. Of those NCI K applicants with medical degrees, the
top three medical specialties were Internal Medicine, Medical
Oncology, and Hematology Oncology. Among K07 appli-
cants, the most common degree fields of study were
Epidemiology, Clinical Psychology, and Public Health,
reflecting emphasis of the K07 mechanism on behavioral
aspects of cancer prevention, control, and population science.
No conclusions could be drawn on K applicant race and
ethnicity in this cohort due to the relatively large proportion
5 The majority of applicants applied to only one NCI K mechanism,
but to control for applicants who submitted applications and/or re-
ceived awards in multiple K mechanisms, we implemented a “primary
K mechanism rule” that places each applicant in a single K mechanism
for analysis of demographics and career outcomes.
6 Individual applicants might have submitted multiple applications to
one or more NCI K mechanism, but only one application per fiscal year
is counted in the overall total. This total also includes applications that
were withdrawn.
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of individuals with unknown or undeclared status (approxi-
mately 30 % for all applicants, including 6 % of awardees and
36 % of non-awardees). Race and ethnicity are voluntarily
reported on NIH grant applications. Moreover, a complete
picture of the contribution of race and ethnicity to K award
success and future outcomes would need to include analysis of
awards administered by NCI’s Center to Reduce Cancer
Health Disparities, which were not included in this evaluation.
Close to half the applicants to the K program had prior
NIH training support which included appointments on
National Research Service Awards institutional (T) grants,
individual fellowships (F), loan repayment contracts (L),
and research7 or other NIH support. Applicants with prior
T grant support had 1.25× higher odds of receiving a K
award (p=0.0051) compared to applicants without prior T
support. For applicants with a prior F award, the odds ratio
was higher (1.28×) compared to applicants without prior F
support, but was not statistically significant, presumably due
to the small number of F awards in the cohort. We tested the
impact of having participated in multiple prior training
grants or fellowships using a three-group chi-square and
found that having more than one training grant or fellowship
had no effect on the probability of K award receipt.
Applicant Institution Demographics
We examined two characteristics of the institutions from which
NCI K applications were received: whether an institution had an
NCI Cancer Center designation, and the level of overall annual
NCI funding the institution received during the evaluation peri-
od. The NCI Cancer Center designation is granted to institutions
with research programs that foster interactions between basic
laboratory, clinical, and population scientists through shared
services, technologies, and other scientific infrastructure.
Across Kmechanisms, the majority of applications (71 %) were
received from and awards (74 %) granted to institutions with
NCI-designated Cancer Centers. Affiliation of an applicant in-
stitution with an NCI-designated Cancer Center was associated
with improved odds for receiving a K award (1.36×, p=0.0005).
Additionally, applicant institution funding level was strongly
correlated with probability of receiving a K award. Applicants
from institutions receiving $10 million or more annual NCI
funding had 1.64× higher odds of receiving a K award (p=
4.83×10−10) than applicants from other institutions.
Gender
Gender distribution and K application success were ana-
lyzed to better understand female representation in the
NCI-supported biomedical workforce. In 2000, men received
7 This includes research project grants such as R03, R21, R29, and
R55.
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Fig. 1 Logic model of NCI K awards outcome evaluation. The logic
model highlights K program inputs, activities, outcomes, and impact,
as well as contextual factors. The inputs include the features
(demographics) that define applicants to the NCI K program, as well
as features of the K mechanisms. Activities include the actions that a
funded researcher would take to further their research training and
career plans, and context refers to specific features of the past and
present environment in which program participants are functioning.
Outcomes include measures that might be attributed to participation in
the NCI K program and are divided into three broad categories of
subsequent funding, productivity, and career appointments. Impact is
assessed by comparing outcomes of closely matched cohorts of K
awardees and non-awardees and examining proxies of scientific re-
search and engagement
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55.2 % of biological and biomedical sciences PhDs and wom-
en received 44.8 % [3]. However, data from 2010 show that
the proportion of men to women receiving biological or bio-
medical sciences PhDs was 47.6 to 52.4 %, respectively,
demonstrating that the gender gap in this field appears to have
closed within the last decade [3]. In contrast, 2008 data show
that 55.8% ofMDdegrees were earned bymen and 44.2% by
women [4]. Across K mechanisms and over almost three
decades of K program history, women comprised 37 % of
program applicants and 37 % of awardees, indicating that,
although women applied in fewer numbers, the proportion of
women who received K awards was commensurate with the
proportion who applied. When examining the proportion of
female and male applicants over the final 2 years of this
evaluation, the percentage of female and male applicants more
closely reflected the near balance seen in the biomedical
workforce data above. The gender similarities in K awardees
mirrored the finding in the NIH pool of newly competing
R01s for first-time investigators—success rates for men and
women are equivalent and any gender disparities in receipt of
new NIH awards are attributable to differences in application
rates rather than differences in success [5, 6].
We also examined resubmission rates for K applications by
gender. Our initial analysis showed that female applicants
were 1.2× more likely to resubmit a K application than male
applicants (p=0.03). However, when the data were stratified
by mechanism, the higher odds ratio was driven primarily by
the K07 applicant pool, in which the majority of K07 awar-
dees (65 %) and non-awardees (63 %) were female. This is
consistent with the K07 program’s focus on PhD applicants in
areas of prevention, control, and behavioral and population
sciences, which have higher percentages of female degree
recipients.8 When K07 applicants were excluded, there was
no significant difference in resubmission rates by gender.
Subsequent Research Funding
We incorporated a variety of metrics to assess career outcomes
and performance of K awardees compared to non-awardees
subsequent to the K program. Unless otherwise indicated,
outcome results focus on the K program as a whole, aggre-
gated across the seven evaluated mechanisms. For this and
several other analyses, we examined K awardees and non-
awardees in both the full cohort and a comparison cohort
consisting of applicants matched on K application priority
score (described in “Methods”). The comparison cohort de-
mographics were similar to the full evaluation population and
are presented in Online Resource 4.
One indicator of scientific research independence is the
attainment of subsequent NIH funding. As shown in Fig. 2,
proportionately more K awardees in the comparison cohort
were awarded grants from NIH Institutes and Centers (in-
cluding NCI) than non-awardees (56 % for awardees, com-
pared to 43 % for non-awardees; p=0.0038). The awarded
grants included P01s, R01s, institutional training grants,
U01s, and other research project grants. This difference
was also observed in the full cohort of awardees and non-
awardees as well (59 % compared to 36 %, respectively) and
reflects findings of the NIH-wide mentored K evaluation,
which analyzed the K01, K08, and K23 mechanisms [7]. We
determined that more K awardees in the comparison cohort
received subsequent grants from NCI than non-awardees
(43 % compared to 29 %, p=0.0008), a finding also ob-
served in the full cohort.
Although not depicted in Fig. 2, we analyzed subsequent
grant activity by ordering grants into 12 achievement, or
“high water mark,” levels as a surrogate for grant funding
longevity, and each NCI K applicant was placed into the
best level according to their subsequent grant record. For
instance, a K applicant who subsequently became a princi-
pal investigator (PI) of an institutional training grant (T32)
was ranked at a greater high water mark than a K applicant
who received an individual R01, since T32 eligibility crite-
ria require the PI to have NIH R01 or R01-like funding.
8 Per the 2010 NSF Survey of Earned Doctorates, over the period of
2000 through 2010, 56 % of social sciences PhDs were granted to
women, and within this category, 69 % of psychology PhDs were
granted to women.















K01 1997–2007 624 153 24.5 479 152 327 31.7
K07 1980–2008 825 274 33.2 562 274 288 48.8
K08 1984–2008 1,638 515 31.4 1,176 514 662 43.7
K11 1987–1996 216 86 39.8 166 86 80 51.8
K22 1998–2008 324 73 22.5 200 57 143 28.5
K23 1999–2008 366 98 26.8 254 98 156 38.6
K25 2000–2008 88 25 28.4 56 25 31 44.6
Total 1980–2008 4,081 1,224 30.0 2,893 1,206 1,687 41.7
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Similarly, a K applicant who subsequently received an R01
was ranked higher than an individual who applied for an
R01 but did not receive funding. K awardees in both the full
and comparison cohorts were more likely to be at a greater
high water mark (e.g., receive R01s, U01s, etc.) than non-
awardees (data not shown).
Additionally, we investigated grant funding from Federal
agencies including DoE, DoD, and NSF and from funding
organizations in the ICRP. Although the numbers of K awar-
dees and non-awardees who received such funding were too
small to draw definitive conclusions, it was clear that K
applicants successfully competed for cancer-related research
funding from sources other than NIH (data not shown).
Time to First R01
One question that has been raised is whether time spent in the
K program impedes timely career progression. We explored
this notion by calculating the length of time to first NIH R01
grant from receipt of K award or from the last unsuccessful K
application (for non-awardees). Overall, the mean time to R01
for awardees and non-awardees was within 1 year of each
other and the distributions had substantial overlap. A Mann–
Whitney test of median differences for all mechanisms com-
bined in the comparison cohort revealed no significant differ-
ence in time to R01 for K awardees and non-awardees (4 and
3.5 years, respectively). The only significant difference in the
full cohort was detected in the K01 mechanism, in which non-
awardees attained their first R01 in 3 years versus the
awardees’ 3.5 years (p=0.02). Yet, the K01 applicants’ medi-
an time to R01 was still shorter than the comparison cohort
median for all K mechanisms combined. These findings re-
flect those seen in the NIH mentored K evaluation [7].
Additionally, the median age at K application for awardees
and non-awardees was similar, between 36 and 37 years.
Therefore, we gauge the age at first R01 for K awardees and
non-awardees to be 40–41 years, in line with the age of NIH
first-time R01equivalent investigators [8].
Publications
In addition to grant funding, peer-reviewed publications are
a relevant indicator of subsequent research activity. Across
all mechanisms combined, a significantly larger proportion
of awardees had subsequent research publications than non-
awardees (89 versus 59 %, respectively; p=2.2×10−16). In
addition to awardees being more likely to publish, among
those who published, the average and median number of
publications per awardee were significantly higher than non-
awardees in the K01, K07, and K23 mechanisms (data not
shown). The other K mechanisms showed similar trends, but
the data did not reach statistical significance.
Research Activity and Engagement in the Scientific
Enterprise
Since the overall goal of the K program is to support individ-
uals as they establish independent cancer research careers, we
created a composite outcome to serve as a proxy for being a
funded researcher. This composite outcome included the fol-
lowing subsequent activities, with each bearing equal weight:
being awarded a competitive grant from the NIH, DoE, or one
of the ICRP organizations or being a key personnel on a
clinical trial registered at ClinicalTrials.gov. In the comparison
cohort, 182/293 (62 %) of K awardees were funded research-
ers as measured by the above proxy, compared to 149/293
(51 %) of non-awardees (p=0.0076). This finding was also
true in the full cohort, where 797/1,204 (66 %) of K awardees
had funded research in comparison to 758/1,685 (45 %) of
non-awardees (p=1.0×10−29).9 Therefore, K awardees had
significantly improved odds of having subsequent funded
research or contributing to research in clinical trials.
It is unreasonable to expect that all K awardees will
continue in funded research careers, especially given the
current sustained flat Federal investment in biomedical re-
search and limited availability of tenure track faculty posi-
tions. The career development opportunities provided by
NCI’s K program may prove valuable for those individuals
9 A total of 2,889 applicants were included in this analysis. Four
individuals were removed due to having degrees not sufficient to
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Fig. 2 Subsequent NIH grant activity of K applicants. Individuals are
represented only once in each bar in the highest category of grant
activity achieved. The solid blue bar represents those who received
subsequent NIH grant funding, and the red cross-hatched bar indicates
those who applied but were unsuccessful. The dotted green and striped
purple bars show individuals who had other activity (such as only a
type 5 non-competing renewal award) or did not have any subsequent
applications to the NIH, respectively. Analysis includes funding from all
NIH Institutes and Centers, including NCI. For the comparison cohort, n=
293 for both awardees and non-awardees; for the full cohort, n=1,206 for
awardees and n=1,687 for non-awardees
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who, although they are not conducting funded research,
continue to participate in the biomedical research enterprise
in some capacity. To determine whether K awardees contin-
ued to work in broader roles in the scientific community, we
developed a composite career outcome variable and referred
to it as being “engaged” in the scientific enterprise, with
each of the included outputs bearing equal weight. All
individuals not captured in the above funded research com-
posite were classified as being engaged or not. The engaged
proxy included individuals who served on Federal advisory
committees or review panels related to biomedical research,
published subsequent research papers, matched to the NED,
were on the current membership rolls of selected scientific
professional societies (AACR, ASCO, or FASEB), or were
listed in the HealthLink/Lodestone database as a health
practitioner. In the comparison cohort, 102/111 (92 %) of
K awardees were subsequently engaged in the scientific
enterprise following their K award, compared to 110/144
(76 %) of non-awardees (p=0.0012). Again, the same trend
was seen in the full cohort where 379/407 (93 %) of K
awardees were engaged, compared to 665/927 (72 %) of
non-awardees (p=8.2×10−21).
It may be argued that inclusion of individuals who are
registered health-care practitioners and/or professional soci-
ety members reflects passive involvement but not active
scientific engagement. Therefore, we refined the engaged
criteria in two different analyses to include only those who
(1) served on Federal advisory committees or review panels
or published subsequent research papers, or matched to
NED or (2) met the above criteria or were listed as current
members of AACR, ASCO, or FASEB. In all analyses, K
awardees in both the comparison and full cohorts had sig-
nificantly improved odds of being engaged in the scientific
enterprise compared to non-awardees.
Variation Between K Mechanisms
The results presented thus far have concentrated on K appli-
cants in the full or comparison cohorts across all seven K
mechanisms. However, each of the K mechanisms varies
slightly in applicant eligibility, field of cancer research, and
award provisions and requirements. Subtle differences in
awardee and non-awardee outcomes between K mecha-
nisms were revealed by several measures, and a few exam-
ples are noted below. In the full cohort, K01, K07, K08,
K11, K22, and K23 awardees had greater odds of subse-
quently receiving an NCI grant (2.29× to 4.34×, with p
values ranging from 0.0032 to 9.18×10−14). The trend was
similar for K25 awardees but did not reach statistical signif-
icance. Likewise, in the comparison cohort, K08 and K23
awardees had greater odds (1.67× and 4.91×) of subsequent
NCI funding (p=0.0489 and p=0.0186, respectively), and
the trend was similar for the other mechanisms but did not
reach statistical significance. When examining service on
Federal advisory committees and review panels, K01 and
K07 awardees in the full cohort had the highest odds of
committee participation (3.06× and 3.34×, respectively; p=
6.19×10−08 and p=5.23×10−12, respectively). Also, in the
full cohort, K01, K07, K08, K11, or K25 awardees had
significantly higher odds (4.73× to 8.15×) of being engaged
compared to non-awardees (p values range from 0.0414 to
2.2×10−08). The trend was similar for K22 and K23 awar-
dees but did not reach statistical significance.
Discussion
The sheer size and longevity of NCI’s K program, combined
with an absence of past evaluation data, presented an op-
portunity to examine performance, track program partici-
pant outcomes, and better understand whether K program
goals were being met through a quantitative, comprehensive
evaluation. Overall, we found that participation in the NCI
K program had a positive impact on the careers of K awar-
dees. This was not only gauged by traditional factors such as
research grant funding and publication productivity but also
by activities that signal engagement within the broader
biomedical research enterprise such as Federal advisory
committee service and membership in scientifically oriented
professional societies.
K awardees were more likely than non-awardees to apply
for and secure subsequent research funding from the NIH.
Additionally, K awardees attained their first R01s in a sim-
ilar amount of time as non-awardees, indicating that the
“protected” time spent on career development activities
through the K program did not hamper timely career pro-
gression to research independence. Although 59 % of K
awardees in the full cohort received an NIH research grant,
84 % of K awardees had some NIH application activity
(applied for or received a grant). It should be noted that
our data provided a snapshot of grant funding activity over a
given time period and included applicants who received
their K awards during the late years of this study (e.g.,
FY06-08), so their K awards had not been completed when
grant outcomes were assessed in FY11. Thus, the percent of
K awardees receiving subsequent grants may be underesti-
mated, especially for the more recent K awardees.
Regardless, our findings are in accord with, or are slightly
higher than, the proportion of K awardees who received
subsequent NIH funding in the NIH mentored K evaluation
[7]. Although it is difficult to make direct comparisons of
grant outcomes between evaluations of career development
programs supported by other organizations due to differ-
ences in evaluation methodologies, data analyses, and pro-
gram goals, a 2003 evaluation of the Burroughs Wellcome
Career Award in the Biomedical Sciences (CABS) program
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indicated that just over 65 % of CABS recipients had sub-
sequent NIH research support [9]. CABS was one of the first
“bridging” awards intended to facilitate the transition to
research independence. The K99/R00 is most similar to
CABS, so a direct comparison between those two programs
would be most appropriate. However, the K99/R00 was not
included in our evaluation because the first NCI K99 awards
were not made until 2007, and sufficient time has not
elapsed to analyze outcomes from this mechanism.
Though the overarching goal of NCI’s K program is to
provide support to develop and facilitate an independent
cancer research program, approximately one-quarter of K
awardees appeared to have pursued other routes in the
broader scientific arena. Outside of academia, we found K
awardees affiliated with government and industry. Without a
discussion group or survey of this subset of K awardees, we
can only speculate on the variety of reasons behind these
career choices, which may include interests outside of re-
search and teaching, work–life balance, compensation, lim-
ited number of available faculty positions, and low NIH
funding rates. Regardless of the reasons, we believe it is
important to recognize the value of other career pathways—
public policy, scientific writing, grants administration,
etc.—that use science for the benefit of society [10, 11].
Perhaps, if exposure to these non-traditional options, dis-
cussion of more clearly defined career trajectories and mod-
els, and training in transferrable professional skills were
widespread in graduate school or earlier stages, it would
better serve the future workforce to more closely align skills,
interests, and careers in biomedical science. This may also
divert some individuals from pursuing independent research
careers before both NCI and the awardees invest time and
resources in the K program. A recent report from the NIH
Advisory Committee to the Director Biomedical Workforce
Group recommended the NIH support additional training
and career development experiences to equip graduate stu-
dents for various career options beyond the academic re-
search track [12].
From a program perspective, several findings from this
evaluation point to opportunities to consider moving for-
ward. Men and women were equally successful in K award
receipt. That finding, together with the trend showing the
share of full-time full professorships held by women with
science and engineering degrees, has risen substantially over
the past three decades [13], have positive implications for
women in science. However, women still comprise only a
little more than 20 % of those holding full-time full profes-
sorships [13], so a need to focus on retention strategies to
increase female representation in the biomedical research
workforce, particularly at the tenure-track faculty stage
[14], remains.
In general, K awardees had comparable successful out-
comes across the multiple K mechanisms explored in this
evaluation. Most often, K awardees’ outcomes showed sim-
ilar trends (e.g., higher median publications per person than
non-awardees), and any differences lie in the magnitude of
the change or in the ability to reach statistical significance,
which was also influenced by individual mechanism size
(applicant pool). Any other differences could be attributed
to features of the target population each mechanism attracts
(e.g., applicants with MDs compared to PhDs). Thus, the
similar outcomes across K mechanisms provide an opportu-
nity to contemplate adjustments to create a simplified and
more inclusive program structure. Consolidating mecha-
nisms to remove the barriers created by the discrete mech-
anisms may offer K applicants more freedom in designing
their research and training experiences and would reflect
NCI’s message of encouraging interdisciplinary research.
As an example, applicants to the K08 and K23 mechanisms
are early stage investigators with clinical or health profes-
sional degrees who desire to have mentored experiences in
basic (K08) or patient-oriented (K23) research. Overall, the
two mechanisms have similar objectives, award duration,
financial support, applicant eligibility, and commitment.
Maintaining a K mechanism to support physician scientist
career development is critical in responding to the dearth of
qualified physician scientists in oncology [15, 16].
Therefore, using one mechanism that unifies the K08 and
K23 applicant pools and invites applications across the
cancer research disciplines could be the first step in facili-
tating seamless opportunities among basic and patient-
oriented physician scientists. A previous report on biomed-
ical workforce training by the National Research Council
noted that the complex nature of NIH’s K program may
discourage applicants [17]. Thus, a closer examination of
potential redundancies or gaps in NCI’s current K portfolio
is justified.
There are several limitations to the current studywarranting
discussion. The evaluation was performed in a quantitative
fashion by extracting, collating, and analyzing data from
extant sources. No new information was collected from K
applicants. Therefore, we lack data from participants on their
assessment of the value of the K program experience and what
they believe were direct effects of participating in the pro-
gram.We could also gain an understanding of why individuals
pursued career paths in various sectors if we surveyed appli-
cants who subsequently became funded researchers or were
involved in other ways in the scientific community.
Construction of the comparison cohort was performed to
minimize effects attributed to selection bias—supporting the
best and brightest—but it still remains a challenge to disen-
tangle career development program effects from career suc-
cesses of highly talented, motivated scientists [18].
Furthermore, we did not have information on whether non-
awardees in either the full or comparison cohorts had career
development awards sponsored by other Federal or private
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funding organizations. Thus, it is unknown if the non-awardee
cohorts truly had no similar career development program
experiences.We also did not directly measure career longevity
since grant funding data were snapshots taken in time, but we
did investigate grant activity by high water mark ranking, as
well as academic faculty rank and proportion of K applicants
who achieved Assistant, Associate, or Full Professor status at
the time data were collected (data not shown). The majority of
K01, K07, K22, K23, and K25 applicants achieved current
ranks at the Assistant or Associate Professor level, and half of
K08 and K11 applicants were at the Associate or Full
Professor level. Across all the K mechanisms analyzed, pro-
portionally more members of the K awardee cohort attained a
current rank of Associate or Full Professor than non-awardees.
This evaluation demonstrates the overall successes of
NCI K program participants and shows through multiple
outcome metrics that, among individuals who were equally
likely to receive K funding, those who participated in the K
program derived additional benefit in pursuing research
careers and participating in the scientific enterprise. The
evaluation was the first of its kind in NCI training program
history, affording a unique opportunity to retrospectively
integrate decades of program data into our reflections of
what constitute successful outcomes of training and career
development programs. The primary objective of NCI’s K
program remains the support of early career cancer scientists
and health professionals at critical junctures to promote
research independence. Moreover, we recognize the value
and necessity of acknowledging additional types of contri-
butions from those who have been scientifically trained. We
encourage others to consider adopting such perspectives
into training program assessments as well.
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